A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on (68)Ga-DOTATATE Uptake in Patients with Neuroendocrine Tumors

Patients with neuroendocrine tumors (NETs) are often treated with somatostatin analogs (SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to misinterpretation of somatostatin receptor imaging with (68)Ga-DOTATATE PET/CT by interfering with tracer–receptor binding....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Nucl Med
Hlavní autoři: Gålne, Anni, Almquist, Helen, Almquist, Martin, Hindorf, Cecilia, Ohlsson, Tomas, Nordenström, Erik, Sundlöv, Anna, Trägårdh, Elin
Médium: Artigo
Jazyk:Inglês
Vydáno: Society of Nuclear Medicine 2019
Témata:
Theranostics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6894372/
https://ncbi.nlm.nih.gov/pubmed/31000584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.119.226332
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky